Literature DB >> 10938500

Canadian consensus conference on the management of viral hepatitis. Canadian Association for the Study of the Liver.

.   

Abstract

These proceedings of a consensus conference on the management of viral hepatitis were sponsored by the Canadian Association for Study of the Liver (CASL) and Health Canada. Experts in various aspects of viral hepatitis presented a review of the medical literature on assigned topics. Three expert panels were convened; they debated assigned topics, which corresponded to the reviews presented earlier. Attempts were made to reach consensus on a number of recommendations about the management of viral hepatitis. The content of the literature reviews, the debates and consensus statements were synthesized into a preliminary document. The report gives some background and offers recommendations aimed at both the general practitioner and the specialist.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938500     DOI: 10.1155/2000/309605

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  13 in total

Review 1.  Interferon-alpha-2b plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Lesley J Scott; Caroline M Perry
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage.

Authors:  Romain Moirand; Marc Bilodeau; Suzanne Brissette; Julie Bruneau
Journal:  Can J Gastroenterol       Date:  2007-06       Impact factor: 3.522

Review 3.  Pediatric issues in new therapies for hepatitis B and C.

Authors:  Kathleen B Schwarz
Journal:  Curr Gastroenterol Rep       Date:  2003-06

4.  Chronic hepatitis B infection in Canada.

Authors:  G Y Minuk; J Uhanova
Journal:  Can J Infect Dis       Date:  2001-11

5.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

6.  The laboratory diagnosis of hepatitis B virus.

Authors:  Mel Krajden; Gail McNabb; Martin Petric
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-03       Impact factor: 2.471

7.  Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients.

Authors:  Maciej Witkos; Qi-Long Yi; Jenny Heathcote; Moira K Kapral; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2006-02       Impact factor: 3.522

8.  Treatment of chronic hepatitis C in a Canadian Aboriginal population: results from the PRAIRIE study.

Authors:  Gerald Y Minuk; Meaghan O'Brien; Kim Hawkins; Didi Emokpare; James McHattie; Paul Harris; Lawrence Worobetz; Karen Doucette; Kelly Kaita; Stephen Wong; Gilles Pinette; Julia Uhanova
Journal:  Can J Gastroenterol       Date:  2013-12       Impact factor: 3.522

Review 9.  Peginterferon-alpha-2a (40kD) plus ribavirin: a review of its use in the management of chronic hepatitis C.

Authors:  Gillian M Keating; Monique P Curran
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Management of chronic hepatitis B and C virus infections.

Authors:  Voranush Chongsrisawat; Yong Poovorawan
Journal:  Indian J Pediatr       Date:  2002-02       Impact factor: 5.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.